Izotropic (OTCMKTS:IZOZF) Releases Quarterly Earnings Results, Misses Expectations By $0.02 EPS

Izotropic (OTCMKTS:IZOZF) announced its quarterly earnings results on Monday. The company reported ($0.01) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.02), Zacks reports.

Izotropic Trading Up 4.2%

Shares of OTCMKTS:IZOZF traded up $0.01 during trading on Monday, hitting $0.14. 12,386 shares of the company’s stock traded hands, compared to its average volume of 22,122. Izotropic has a 52 week low of $0.10 and a 52 week high of $0.37. The company has a 50-day moving average price of $0.17 and a 200-day moving average price of $0.18.

Izotropic Company Profile

Izotropic Corporation is a medical technology company focused on developing advanced breast-imaging systems. Its primary product is the IzoView breast computed tomography (CT) system, which is designed to generate three-dimensional images of the breast and support the detection and evaluation of breast disease.

Unlike conventional mammography, the IzoView system is designed to image the breast without the same type of compression used in standard mammographic procedures. The company has also explored contrast-enhanced breast CT applications, with the goal of providing additional information for clinicians assessing suspicious findings and other breast conditions.

Izotropic is based in Richmond, British Columbia, Canada, and is focused on product development, clinical validation, regulatory activities and potential commercialization of its imaging technology.